Alexandre Fourcade
Brest, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
External Validation of the PROMOD Strategy, Combining PI-RADS Score and PSA Density, to Select Patients for Prostatic Biopsies.
Journal: Research and reports in urology
Published: March 29, 2026
Incidence of Significant Prostate Cancer in the Follow-Up of Patients With Suspicious Lesion on MRI and Negative Targeted and systematic Biopsies.
Journal: Clinical genitourinary cancer
Published: August 19, 2024
Refining clinically relevant cut-offs of prostate specific antigen density for risk stratification in patients with PI-RADS 3 lesions.
Journal: Prostate cancer and prostatic diseases
Published: May 19, 2024
External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.
Journal: World journal of urology
Published: April 04, 2024
Predicting contralateral extraprostatic extension in unilateral high-risk prostate cancer: a multicentric external validation study.
Journal: World journal of urology
Published: February 15, 2024
Transperineal or Transrectal Magnetic Resonance Imaging-targeted Biopsy for Prostate Cancer Detection.
Journal: European urology focus
Published: November 28, 2023
The impact of prostate volume estimation on the risk-adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score.
Journal: World journal of urology
Published: November 20, 2023
The Added Value of Side-specific Systematic Biopsy in Patients Diagnosed by Magnetic Resonance Imaging-targeted Prostate Biopsy.
Journal: European urology oncology
Published: September 27, 2023
Which protocol for prostate biopsies in patients with a positive MRI? Interest of systematic biopsies by sectors.
Journal: Prostate cancer and prostatic diseases
Published: July 27, 2023
MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patients.
Journal: Prostate cancer and prostatic diseases
Published: April 06, 2023
Last Updated: 09/26/2026